Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

299

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

July 2, 2024

Study Completion Date

June 30, 2026

Conditions
Multiple MyelomaHodgkin DiseaseNon-Hodgkin Lymphoma
Interventions
OTHER

Acupuncture

Acupuncture treatments will be scheduled to cover the period of high symptom burden. Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. Electrical stimulation (e-acupuncture) may be applied to the ST36 and SP6 points when appropriate as per standard acupuncture practice.

DRUG

opioid

All study patients will receive the usual HSCT care and pain management regimens (usually opioids) as per standard practice at the study institution.

OTHER

Assessments

Participants will be asked to complete patient reported outcomes assessments online using REDCap or, If they prefer, via pencil and paper or over the phone. Assessments at baseline (within 4 weeks before HiChemo) and on or about days 7, 15, 30, and 90 after the first dose of HiChemo.

Trial Locations (3)

10065

Memorial Sloan Kettering Cancer Center, New York

98109

Fred Hutchinson Cancer Research Center, Seattle

Seattle Cancel Care Alliance (Data Collection Only), Seattle

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

Hackensack Meridian Health

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT04459416 - Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma | Biotech Hunter | Biotech Hunter